LivaNova (LIVN) Total Liabilities (2014 - 2026)
LivaNova's (LIVN) quarterly Total Liabilities came in at $1.3 billion in Q2 2026, down 4.94% year-over-year from $1.4 billion in Q2 2025, and up 0.81% quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
LivaNova (LIVN) Total Liabilities (2014 - 2026) Analysis & Trends
LivaNova has disclosed Total Liabilities across 13 years of filings, most recently posting $1.3 billion for Q2 2026.
- In Q2 2026, Total Liabilities fell 4.94% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.3 billion (down 4.94% YoY), while the FY2025 annual figure was $1.4 billion, up 18.54% from the prior year.
- Total Liabilities came in at $1.3 billion for Q2 2026 at LivaNova, up from $1.3 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.5 billion in Q1 2025 to a low of $1.1 billion in Q2 2022.
- Average Total Liabilities over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
- Year-over-year, Total Liabilities retreated 22.26% in 2022 and advanced 23.13% in 2025.
- Over 5 years, Total Liabilities stood at $1.1 billion in 2022, then advanced by 5.96% to $1.2 billion in 2023, then increased by 2.97% to $1.2 billion in 2024, then climbed by 18.54% to $1.4 billion in 2025, then slipped by 6.44% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $1.3 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.4 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.45 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 2.58 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 42.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.94 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 20.04 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 3.14 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 9.50 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.83 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.51 Bn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 1.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Bn |
| Mar 31, 2026 | 1.31 Bn |
| Dec 31, 2025 | 1.41 Bn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 1.38 Bn |
| Mar 31, 2025 | 1.52 Bn |
| Dec 31, 2024 | 1.19 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.24 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 1.10 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.09 Bn |
| Sep 30, 2022 | 1.07 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.13 Bn |
| Dec 31, 2021 | 906.31 Mn |
| Sep 30, 2021 | 890.91 Mn |